Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
ICICI Securities
Equibles does not estimate personal net worth.
Abdul Qadir Puranwala is recorded as Analyst at ICICI Securities. Abdul Qadir Puranwala has spoken on 4 earnings calls across 4 companies, most recently for Piramal Pharma Limited on October 28, 2026. Those appearances were for Piramal Pharma Limited, Jupiter Life Line Hospitals Limited, Cipla Limited and Sun Pharmaceutical Industries Limited. The companies whose calls Abdul Qadir Puranwala spoke on are classified in the Healthcare sector.
“Thank you for the opportunity, and thanks for making these disclosures on a first-half basis. My first question is with regards to the ADC revenue and the uptick, what we have seen.”
“Yeah, thank you for the opportunity, and congrats on that early EBITDA break-even for our own-year EBITDA break-even for Dumbivli.”
“So, my first question is with regards to your billion dollar revenue guidance. So, if I look at your current run rate of say 162 million, what you have done for this quarter.”
“So my first question is with regards to your specialty products under development and specifically to MM2. So, we're now planning for, you know, a partnership.”
ICICI Securities
Analyst
Transcript header (unverified)
Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Jupiter Life Line Hospitals Limited
Medical Care Facilities · Healthcare
Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Piramal Pharma Limited
Earnings Call for the Quarter Ended September 30, 2026
Jupiter Life Line Hospitals Limited
Earnings Call
Cipla Limited
Sun Pharma Q4 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited